GEODE CAPITAL MANAGEMENT, LLC

Holdings History for Terns Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (TERN)

Symbol: TERN on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.01%	+0%	$84,723,240	2,096,642	+382,090	+22%	$40.41	Q4 2025
30 Sep 2025	0%	+0%	$12,879,165	1,714,552	+81,203	+5%	$7.51	Q3 2025
30 Jun 2025	0%	+0%	$6,093,712	1,633,349	+59,145	+3.8%	$3.73	Q2 2025
31 Mar 2025	0%	+0%	$4,345,423	1,574,204	+57,726		$2.76	Q1 2025
31 Dec 2024	0%	+0%	$8,402,530	1,516,478	+308,999	+26%	$5.54	Q4 2024
30 Sep 2024	0%	+0%	$10,071,620	1,207,479	+85,617	+7.6%	$8.34	Q3 2024
30 Jun 2024	0%	+0%	$7,640,694	1,121,862	+255,941	+30%	$6.81	Q2 2024
31 Mar 2024	0%	+0%	$5,681,197	865,921	+25,462	+3%	$6.56	Q1 2024
31 Dec 2023	0%	+0%	$5,455,074	840,459	+52,344	+6.6%	$6.49	Q4 2023
30 Sep 2023	0%	0%	$3,964,641	788,115	+604	+0.08%	$5.03	Q3 2023
30 Jun 2023	0%	+0%	$6,890,721	787,511	+482,795	+158%	$8.75	Q2 2023
31 Mar 2023	0%	+0%	$3,607,837	304,716	+127,068	+72%	$11.84	Q1 2023
31 Dec 2022	0%	+0%	$1,808,000	177,648	+8,800	+5.2%	$10.18	Q4 2022
30 Sep 2022	0%	+0%	$994,000	168,848	+89,524	+113%	$5.89	Q3 2022
30 Jun 2022	0%	-0%	$196,000	79,324	-99,987	-56%	$2.47	Q2 2022
31 Mar 2022	0%	-0%	$532,000	179,311	-1,624	-0.9%	$2.97	Q1 2022
31 Dec 2021	0%	-0%	$1,279,000	180,935	-12,401	-6.4%	$7.07	Q4 2021
30 Sep 2021	0%	+0%	$2,014,000	193,336	+50,267	+35%	$10.42	Q3 2021
30 Jun 2021	0%	+0%	$1,754,000	143,069	+12,806	+9.8%	$12.26	Q2 2021
31 Mar 2021	0%	+0%	$2,865,000	130,263	+130,263	NEW	$21.99	Q1 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.